Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Measles vaccine, HIV infection, and antiretroviral therapy--a window of opportunity.

Maldonado Y.

J Infect Dis. 2012 Aug 15;206(4):466-8. doi: 10.1093/infdis/jis392. Epub 2012 Jun 12. No abstract available.

PMID:
22693235
[PubMed - indexed for MEDLINE]
Free Article
2.

Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity.

Scott P, Moss WJ, Gilani Z, Low N.

J Infect Dis. 2011 Jul;204 Suppl 1:S164-78. doi: 10.1093/infdis/jir071. Review.

PMID:
21666158
[PubMed - indexed for MEDLINE]
Free Article
3.

Immune reconstitution after highly active anti-retroviral treatment of HIV infection.

Autran B, Carcelain G, Debre P.

Adv Exp Med Biol. 2001;495:205-12. Review. No abstract available.

PMID:
11774568
[PubMed - indexed for MEDLINE]
4.

[Immune mechanisms in HIV infection and their role in antiretroviral therapy].

Smiatacz T.

Przegl Epidemiol. 2003;57(2):309-16. Review. Polish.

PMID:
12910599
[PubMed - indexed for MEDLINE]
5.

Treatment of primary HIV infection.

Daar ES.

MedGenMed. 2002 Nov 15;4(4):15. Review. No abstract available.

PMID:
12817211
[PubMed - indexed for MEDLINE]
Free Article
6.

A pathophysiological approach to antiretroviral therapy.

Lesho E.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):509-20. Review.

PMID:
15482217
[PubMed - indexed for MEDLINE]
7.

Structured treatment interruptions in HIV/AIDS therapy.

Lisziewicz J, Lori F.

Microbes Infect. 2002 Feb;4(2):207-14. Review.

PMID:
11880054
[PubMed - indexed for MEDLINE]
8.

Intermittent therapy for the treatment of chronic HIV infection.

Ananworanich J, Hirschel B.

AIDS. 2007 Jan 11;21(2):123-34. Review. No abstract available.

PMID:
17197802
[PubMed - indexed for MEDLINE]
9.

Effects of antiretroviral therapy on immune reconstitution.

Autran B.

Antivir Ther. 1999;4 Suppl 3:3-6. Review.

PMID:
16021864
[PubMed - indexed for MEDLINE]
10.

Immunomodulants for the treatment of HIV infection: the search goes on.

Clerici M.

Expert Opin Investig Drugs. 2006 Mar;15(3):197-200. Review.

PMID:
16503756
[PubMed - indexed for MEDLINE]
11.

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy.

Carcelain G, Debré P, Autran B.

Curr Opin Immunol. 2001 Aug;13(4):483-8. Review.

PMID:
11498306
[PubMed - indexed for MEDLINE]
12.

Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

Verma R, Khanna P, Bairwa M, Chawla S, Prinja S, Rajput M.

Hum Vaccin. 2011 Oct;7(10):1109-11. Review.

PMID:
22238787
[PubMed - indexed for MEDLINE]
13.

HIV, atherosclerosis and inflammation: implications for treatment.

Chan W, Sviridov D, Dart AM.

J HIV Ther. 2009 Nov;14(3):61-8. Review. No abstract available.

PMID:
20218241
[PubMed - indexed for MEDLINE]
14.

25 years after HIV discovery: prospects for cure and vaccine.

Montagnier L.

Virology. 2010 Feb 20;397(2):248-54. doi: 10.1016/j.virol.2009.10.045. Review. No abstract available.

PMID:
20152474
[PubMed - indexed for MEDLINE]
Free Article
15.

Primary HIV-1 infection: to treat or not to treat?

Blankson JN.

AIDS Read. 2005 May;15(5):245-6, 249-51. Review.

PMID:
15900634
[PubMed - indexed for MEDLINE]
16.

Interrupting highly active antiretroviral therapy in patients with HIV.

Ananworanich J, Hirschel B.

Expert Rev Anti Infect Ther. 2005 Feb;3(1):51-60. Review.

PMID:
15757457
[PubMed - indexed for MEDLINE]
17.

Managing failure to antiretroviral drugs in HIV-1-infected patients.

Gianotti N, Lazzarin A.

Int J Immunopathol Pharmacol. 2003 Jan-Apr;16(1):9-18. Review.

PMID:
12578726
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk